Skip to main content

Day: June 13, 2022

Novation of Investment Management Agreement

Downing FOUR VCT plc LEI: 21380035MV1VRYEXPR9513 June 2022Sale of Downing Ventures business to Foresight Group – Novation of Investment Management Agreement  Downing FOUR VCT plc (“Downing FOUR” or “the “Company”), announces that its investment manager, Downing LLP (“Downing”), has agreed to sell its non-Healthcare Ventures business to Foresight Group Holdings Limited (“Foresight”).   The Board has agreed to the novation of the Investment Management Agreement (with the exception of the management of the Healthcare share pool) from Downing to Foresight, subject to completion of the sale. The whole Downing Ventures team (excluding members of the Healthcare team) and key support staff are expected to transfer to Foresight as part of the transaction.  The management of the Healthcare share pool will be retained by Downing and continue to be...

Continue reading

Novation of Investment Services Agreement

Downing ONE VCT plc LEI: 213800R88MRC4Y3OIW8613 June 2022Sale of Downing Ventures business to Foresight Group – Novation of Investment Services Agreement   Downing ONE VCT plc (“Downing ONE” or “the “Company”) announces that its investment adviser, Downing LLP (“Downing”), has agreed to sell its non-Healthcare Ventures business to Foresight Group Holdings Limited (“Foresight”).   The Board has agreed to the novation of the Investment Services Agreement with Downing to Foresight, subject to completion of the sale. The whole of the Downing Ventures team and key support staff are expected to transfer to Foresight pursuant to the sale and Downing will continue to provide administration services, and investment advisory services in respect of non-ventures portfolio investments (mainly AIM-quoted and yield focussed investments) for a transitional...

Continue reading

Subsea 7 revises 2022 guidance

Luxembourg – 13 June 2022 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today updated its Adjusted EBITDA guidance for the full year 2022. Seaway 7 ASA1 announced today provisions against the results of project execution of offshore windfarm installations due to increased costs relating to weather delays and mechanical breakdowns. This, together with an increase in the existing provision on the Formosa 2 project2, including the effects of Covid-19, will impact Subsea 7’s Adjusted EBITDA for 2022, which is still expected to be broadly in line with 2021. 1 Seaway 7 ASA is listed on Euronext Growth (SEAW7) and its financial statements are consolidated as part of the Subsea 7 Group. 2 As part of the combination agreement between Subsea 7’s fixed offshore wind renewable segment and OHT AS to form Seaway 7 ASA, the economic interest on...

Continue reading

Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron

Sanofi–GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including OmicronNext-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger immune response compared to Pfizer-BioNTech’s Comirnaty booster vaccine Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profileParis – June 13, 2022 – Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with its new next-generation COVID-19 booster vaccine candidate modelled on the Beta variant antigen and including GSK’s pandemic adjuvant. In the Phase 3 VAT02 Cohort 2 study, the Sanofi-GSK next–generation vaccine...

Continue reading

Bone Therapeutics to host Extraordinary General Meeting on 13 July 2022

REGULATED INFORMATIONPreliminary documents for the Extraordinary General Meeting have been made available on company’s websiteMont-Saint-Guibert, Belgium, 13 June 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the extraordinary general meeting to be held on Wednesday 13 July 2022 as from 11:00 am CEST, at Rue du Fort 24, 6000 Charleroi, Belgium. The notice for the extraordinary general meeting, including the agenda of the day as well as the motions to vote, is published today in the Belgian Official Gazette and La Libre Belgique. The documents and preliminary information concerning the extraordinary general meeting...

Continue reading

REC Silicon – REC Silicon and Ferroglobe Announce MOU for Solar Supply Chain Expansion

Moses Lake, Washington USA June 13, 2022: Hanwha Group investment and potential passage of SEMA legislation provides spark to expand U.S. production of polysilicon and metallurgical grade silicon. REC Silicon and Ferroglobe today announce a Memorandum of Understanding committing the companies to negotiate a raw material supply agreement and establish a low-carbon and fully traceable U.S.-based solar supply chain. Recent investment by the Hanwha Group into REC Silicon, in conjunction with Hanwha’s subsidiary Qcells, has sparked the impetus to expand REC’s long-standing relationship with Ferroglobe and plan for the immediate development of an end-to-end U.S. solar supply chain from raw silicon, to polysilicon, and finally fully assembled modules. The impact of such investment would span from Washington State, to Georgia, West Virginia, and...

Continue reading

Abra Health Acquires Multi-Specialty Dental Practice in Kearny, NJ

ROSELAND, N.J., June 13, 2022 (GLOBE NEWSWIRE) — Abra Health (recently rebranded from The ChildSmiles Group) enthusiastically announces the acquisition of For All Children and Adult Dentistry, a multi-specialty dental practice in Kearny, New Jersey. The practice will be renamed Abra Dental and will continue to welcome patients for pediatric and adult dentistry as well as orthodontics. Kearny, NJ Mayor Alberto G. Santos will be officiating a ribbon-cutting ceremony announcing the renaming and expansion of the practice on July 7th at 5:30 pm. The public is invited to attend. For All Children and Adult Dentistry has been providing top-quality pediatric and adult dental care to Kearny residents for over 30 years. Founded in 2008, Abra Dental embraces the addition of the Kearny-based practice to their existing three Abra Dental practices...

Continue reading

Prairie Provident Updates 2022 Capital Budget and Non-Core Disposition Process

CALGARY, Alberta, June 12, 2022 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident”, “PPR” or the “Company”) is pleased to announce an update to its 2022 capital budget and non-core disposition process. MESSAGE TO SHAREHOLDERS Tony Berthelet, President & Chief Executive Officer, commented: “Given significantly higher oil and natural gas prices, PPR has chosen to pivot our second half 2022 capital program toward non-core reactivations, recompletions and optimization projects to maximize shareholder value. In addition, we expect to drill a Glauconite formation well at Princess as previously announced. The anticipated benefits of this change in scope include improved reserve additions, incremental unhedged revenue, low risk capital execution, and an improved corporate liability rating. This capital program...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.